| Literature DB >> 33452959 |
Koen Andre Horstink1, Lucas Henricus Vincentius van der Woude1,2,3, Juha Markus Hijmans4,5.
Abstract
Patients with diabetic peripheral neuropathy (DPN) usually have reduced somatosensory information and altered perception in feet and ankles. Somatosensory information acts as feedback for movement control and loss of somatosensation leads to altered plantar pressure patterns during gait and stance. Offloading devices are used to reduce peak plantar pressure and prevent diabetic foot ulcers. However, offloading devices can unfortunately have negative effects on static and dynamic balance. It is important to investigate these unwanted effects, since patient with DPN already are at high risk of falling and offloading devices could potentially increase this risk. The aim of this systematic review is to investigate the effects of plantar offloading devices used for ulcer prevention on their role in static and dynamic balance control in patients with DPN. PubMed and Embase were systematically searched using relevant search terms. After title selection, abstract selection, and full-text selection only five articles could be included for further analysis. Two articles included static balance measurements, two articles included dynamic balance measurements, and one article included both. Results suggested that static balance control is reduced when rocker bottom shoes and different insole configurations are used, however, toe-only rockers showed less evidence for reduced static balance control. There was no evidence for reduced dynamic balance control in combination with offloading devices. However, these results should be interpreted with care, since the number of studies was very small and the quality of the studies was moderate. Future research should evaluate balance in combination with different offloading devices, so that clinicians subscribing them are more aware of their potential unwanted consequences.Entities:
Keywords: Balance; Neuropathy; Offloading
Mesh:
Year: 2021 PMID: 33452959 PMCID: PMC8087551 DOI: 10.1007/s11154-020-09619-9
Source DB: PubMed Journal: Rev Endocr Metab Disord ISSN: 1389-9155 Impact factor: 6.514
Fig. 1Quality assessment tool modified from van der Wilk et al. [19]. RT = randomized trial, COT = cross over trial, y = yes (low risk of bias), n = no (high risk of bias),? = unclear (uncertain risk of bias), NA = not applicable
Fig. 2Flow-chart of the literature selection process, modified from the PRISMA statement [23]. The literature search was performed in PubMed and Embase
Results of the quality assessment for the five included studies. The numbers correspond to the criteria as shown in in Fig. 1
| Author | Reference | Observational design | General | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4a | 4b | 5 | 6 | 7 | 8 | 9 | ||
| Ghomian et al. | [ | y | y | na | na | na | ? | ? | y | y | y |
| Ghomian et al. | [ | y | y | n | n | ? | ? | ? | y | y | y |
| Paton et al. | [ | y | y | na | na | na | ? | ? | y | y | y |
| Albright et al. | [ | y | y | na | na | na | n | ? | y | n | y |
| Grewald et al. | [ | n | y | ? | n | ? | ? | ? | y | y | n |
y yes (low risk of bias), n no (high risk of bias),? unknown or no information (uncertain risk of bias)
Fig. 3Schematic overview of the rocker bottom shoes used by Albright et al. [26] and Ghomian et al. [24, 25]. Numbers 1–3 correspond to the conditions used by Albright et al. [26], numbers 4 and 5 correspond to the conditions used by Ghomian et al. [24], and numbers 6–8 correspond to the conditions used by Ghomian et al. [25]. (1) = Control shoe; (2) rocker bottom shoe with rocker apex positioned at 60–65% of the shoe length; (3) negative heel shoe with rocker apex at 60–65% of the shoe length and from rocker apex to heel the sole was reduced to zero thickness; (4) rocker bottom shoe with rocker apex position at 62.5% of the shoe length and a rocker angle of 23°; (5) baseline shoe; (6) Rocker bottom shoe with rocker angle of 10°, apex position at 60% of the shoe length, and apex angle of 80°; (7) rocker bottom shoe with rocker angle of 15°, apex position at 55% of the shoe length, and apex angle of 80°; (8) rocker bottom shoe with rocker angle of 20°, apex position at 60% of the shoe length, and apex angle of 95°
Overview of the included studies with their characteristics and outcomes
| Author | Design | N | Gender | Participants | Device | Control | Methods | Balance outcome measures | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
| (Ref) | (M/F) | Age (SD) | Type | Balance task | Acquisition | Static outcome measures | Dynamic outcome measures | ||||
| Paton et al. [ | Within-subject | 50 | 38 M 12 F | 71 (8.0) | DPN | SI RAI LRMI TI | No insole | Stance PS SRT | Force plate 1–10 scale In-shoe pressure | COPv ↑ 13.1%** LMRI vs CO; ↑ 14.2%* SI vs CO COPv ↑ 9.3%* LMRI vs TI; ↑ 9.9%* LMRI vs RAI COPl ↑ 13.2%** LMRI vs CO; ↑ 14.2%* SI vs CO COPl ↑ 9.4%* LMRI vs TI; ↑ 10.1%* LMRI vs RAI | No significant effects SRT No significant effects PS |
| Albright et al. [ | Within-subject | 20 | 3 M 16 F | Range: 22–25 | H | RB NH | Control shoe | Stance with perturbation | Force plate | COMs ↑ 25.1%* RB vs CO; ↑ 28.6%* NH vs CO COMvar ↑ 19.3%* RB vs CO; ↑ 22.0%* NH vs CO COMapv ↓ 17.6%* RB vs CO; ↓ 20.0%* NH vs CO COMsr ↑ 9.5%* RB vs CO; ↑ 10.5* NH vs CO COMppv ↓11.9%ns RB vs CO;↓ 18.4%* NH vs CO COPs ↑ 15.0%* RB vs CO; ↑ 18.2%* NH vs CO COPvar ↑ 6.5%* RB vs CO; ↑ 8.6%* NH vs CO COPapv ↓ 13.9%* RB vs CO; ↓ 10.1%* NH vs CO COPppv ↓ 14.5%* RB vs CO; ↓ 11.7%* NH vs CO COPsr ↑ 0.1%ns RB vs CO; ↑ 0.0%ns NH vs CO FSM ↓ 23.7%* RB vs CO; ↓ 24.1%* NH vs CO | |
| Grewald et al. [ | Between-subject | 39 | Unkown | 54.2 (11.3) 58.3 (4.4) 59.6 (6.0) | 15 DPN 16 DPNU 8 H | OF OS RCW HF | Healthy persons with HF | Walking 200 ft | Wearable sensors | DS ↑ 26.4%* DPN vs CO DS ↑ 6.3%ns DPNU vs CO DS ↑ 19.0%* DPN vs DPNU COMs ↓ 34%* DPN vs CO COMs ↓ 47%** DPNU vs CO COMs ↑ 23%ns DPN vs DPNU | |
| Ghomian et al. [ | Within-subject | 17 | 7 M 7 F | 49.3 (7.5) | DPN | TR | Control shoe | Stance with perturbation | Dual force plate | COFd mean all perturbations ↑ 6.2%ns TR vs GS RSS backward large perturbation ↓ 23.3%ns TR vs GS RSS mean other perturbations ↑ 24.5%* TR vs GS RL mean all perturbations ↓ 3.9%ns TR vs GS | |
| Ghomian et al. [ | Between-subject | 34 | 12 M 22 F | 58.7 (4.7) 54.4 (5.1) 33.2 (2.0) | 9 DPN 14 DM 11 H | TR10 TR15 TR20 | Barefoot | 10 m walking | Vicon | No significant effects SMOS1 FMOS↓ 6.2%ns B vs TR101 FMOS ↓ 9.3%* B vs TR151 FMOS ↓ 5.7%ns B vs TR201 FMOS ↓ 2.9%ns TR10 vs TR151 FMOS ↑ 0.5%ns TR10 vs TR201 FMOS ↑ 3.4%ns TR15 vs TR201 | |
Ref = reference, Device = offloading device, N = number of participants, M = male, F = Female, H = healthy persons, DPNU = diabetic peripheral neuropathy with ulcers, DM = diabetic patients without neuropathy, SI = standard diabetic insole, RAI = insole with removed arch fill, LRMI = insole with low resilient memory cover, TI = insole with textured PVC cover, RB = rocker bottom shoes, NH = negative heel shoes, OF = offloading footwear, OS = offloading sandals, RCW = removable cast walker, HF = habitual footwear, FS = specific flexible shoes, RS = specific rigid shoes, US = usual footwear, TR = Toe-only Rocker, GS = gymnastic shoe, MF = midfoot, RF = rearfoot, CO = compared to control condition, PS = perceived stability, SRT = step reaction time, PDT = peak duration time, CoP = Centre of Pressure, CoM = Centre of Mass, COPv = CoP velocity, COPl = CoP path length, COPs = CoP sway amplitude, COPvar = CoP sway variance, COPapv = CoP anterior peak velocity, COPppv = CoP posterior peak velocity, COPsr = CoP sway range, COPsur = CoP surface, COMs = CoM sway amplitude, COMvar = CoM sway variance, COMapv = CoM anterior peak velocity, COMsr = CoM sway range, COMppv = CoM posterior peak velocity, COFd = centre of force displacement, RSS = response strength scale, RL = response latency, PDT = peak duration time, DS = double support stance, DPN = diabetic peripheral neuropathy, ML = medial-lateral and AP = anterior-posterior
aOnly results of diabetic peripheral neuropathy patients are shown; * indicate a significant difference with p < 0.05; ** indicates a significant difference with p < 0.01; ns = non-significant